These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24900429)

  • 1. Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds.
    Torres E; Fernández R; Miquet S; Font-Bardia M; Vanderlinden E; Naesens L; Vázquez S
    ACS Med Chem Lett; 2012 Dec; 3(12):1065-9. PubMed ID: 24900429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azapropellanes with anti-influenza a virus activity.
    Torres E; Leiva R; Gazzarrini S; Rey-Carrizo M; Frigolé-Vivas M; Moroni A; Naesens L; Vázquez S
    ACS Med Chem Lett; 2014 Jul; 5(7):831-6. PubMed ID: 25050174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus.
    Rey-Carrizo M; Barniol-Xicota M; Ma C; Frigolé-Vivas M; Torres E; Naesens L; Llabrés S; Juárez-Jiménez J; Luque FJ; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2014 Jul; 57(13):5738-47. PubMed ID: 24941437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.
    Nguyen JT; Hoopes JD; Le MH; Smee DF; Patick AK; Faix DJ; Blair PJ; de Jong MD; Prichard MN; Went GT
    PLoS One; 2010 Feb; 5(2):e9332. PubMed ID: 20179772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study of the Activity of Adamantyl Amines against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple Blocker, Explored by Molecular Dynamics Simulations and Solid-State NMR.
    Stampolaki Μ; Hoffmann A; Tekwani K; Georgiou K; Tzitzoglaki C; Ma C; Becker S; Schmerer P; Döring K; Stylianakis I; Turcu AL; Wang J; Vázquez S; Andreas LB; Schmidtke M; Kolocouris A
    ChemMedChem; 2023 Aug; 18(16):e202300182. PubMed ID: 37377066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adamantan derivatives capable of inhibiting the reproduction of a Rimantadine resistant strain of influenza A(H1N1)pdm09 virus (Influenza A virus, Alphainfluenzavirus, Orthomyxoviridae).].
    Garaev TM; Odnovorov AI; Kirillova ES; Burtseva EI; Finogenova MP; Mukasheva EA; Grebennikova TV
    Vopr Virusol; 2020; 65(1):16-20. PubMed ID: 32496716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.
    Nguyen JT; Hoopes JD; Smee DF; Prichard MN; Driebe EM; Engelthaler DM; Le MH; Keim PS; Spence RP; Went GT
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4115-26. PubMed ID: 19620324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isocyanides as Influenza A Virus Subtype H5N1 Wild-Type M2 Channel Inhibitors.
    Wu S; Huang J; Gazzarrini S; He S; Chen L; Li J; Xing L; Li C; Chen L; Neochoritis CG; Liao GP; Zhou H; Dömling A; Moroni A; Wang W
    ChemMedChem; 2015 Nov; 10(11):1837-45. PubMed ID: 26506405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ritter reaction-mediated syntheses of 2-oxaadamantan-5-amine, a novel amantadine analog.
    Leiva R; Gazzarrini S; Esplugas R; Moroni A; Naesens L; Sureda FX; Vázquez S
    Tetrahedron Lett; 2015 Mar; 56(10):1272-1275. PubMed ID: 32287445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice.
    Masihi KN; Schweiger B; Finsterbusch T; Hengel H
    J Chemother; 2007 Jun; 19(3):295-303. PubMed ID: 17594925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
    Rey-Carrizo M; Torres E; Ma C; Barniol-Xicota M; Wang J; Wu Y; Naesens L; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2013 Nov; 56(22):9265-74. PubMed ID: 24237039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.
    Duque MD; Ma C; Torres E; Wang J; Naesens L; Juárez-Jiménez J; Camps P; Luque FJ; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2011 Apr; 54(8):2646-57. PubMed ID: 21466220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling.
    Tran L; Choi SB; Al-Najjar BO; Yusuf M; Wahab HA; Le L
    Molecules; 2011 Dec; 16(12):10227-55. PubMed ID: 22158591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA; Bovin NV; Webster RG; Govorkova EA
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada.
    Higgins RR; Eshaghi A; Burton L; Mazzulli T; Drews SJ
    J Clin Virol; 2009 Jan; 44(1):91-3. PubMed ID: 19019729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues.
    Kolocouris A; Spearpoint P; Martin SR; Hay AJ; López-Querol M; Sureda FX; Padalko E; Neyts J; De Clercq E
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6156-60. PubMed ID: 18947998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
    Takeda M; Pekosz A; Shuck K; Pinto LH; Lamb RA
    J Virol; 2002 Feb; 76(3):1391-9. PubMed ID: 11773413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001.
    Schmidtke M; Zell R; Bauer K; Krumbholz A; Schrader C; Suess J; Wutzler P
    Intervirology; 2006; 49(5):286-93. PubMed ID: 16809934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.